Category Archives: Cancer Survivors

Scientists Pursue Creative Cancer Detection Techniques

Cancer Detection
Cancer Detection

The earlier a cancer is found and properly diagnosed, the better the odds of effectively treating the disease. At Issels® Integrative Immuno-Oncology, we understand that different types of cancer behave differently and the best approach is individualized treatment protocols based on each person’s diagnosis. Scientists are now using nanoparticles and cancer sniffing dogs to detect cancer.

These nanoparticles (called nanoflares) connect with cancer cells in blood, causing those same cells to glow. The nanoflares are tiny gold particles that have been coated with luminescent molecules and specifically selected DNA that correlates with the RNA of different cancer cells.

Scientist are hoping to be able to identify different types of cancer by using particular DNA and various colors of molecules.

Google is looking for ways to create pills and wearables incorporating the nanoflares that would simplify the screening process and improve the accuracy of cancer diagnosis. These devices would constantly monitor for cancer cells within the individual, according to the Wall Street Journal.

Different organizations in the United States and UK are attempting to train dogs to screen patients for cancer. Many feel this non-invasive approach could be used for pancreatic and stomach cancers that do not currently have screening methods. The British Medical Journal has already published the results of successful canine scent cancer detection for prostate cancer.

For more than 60 years, Issels® Integrative Immuno-Oncology has been successfully treating cancer with innovative immunotherapy and non-toxic treatment methods. If you or a loved one is diagnosed with cancer, you do have options. Contact us for more information.

Researchers Harness the HIV Virus to Fight Leukemia

New Cancer Research Is In the News
New Cancer Research Is In the News

The initials “HIV” are rarely associated with positive health news. In an amazing breakthrough, researchers at Penn Medicine have had success using the HIV virus to treat patients with incurable leukemia.

Dr. Carl June and his team at the University of Pennsylvania Health System have been working on the therapy for 20 years. The key to this treatment is the characteristic of the HIV virus to insert new genes into cells.

The procedure begins with billions of T-cells being removed from a patient’s body. A disabled form of HIV is then used to reprogram the T-cells, rendering them capable of recognizing, targeting and killing the cancer. At this point they are returned to the patient’s body to perform their mission.

According to Dr. June, once the cancer has been treated these “killer cells” become dormant, returning to action only if the cancer recurs. Out of 12 patients who have received the treatment, nine are in full or partial remission.

One of the successful cases is that of Marshall Jensen, a newlywed and young parent from Utah who was diagnosed with acute lymphoblastic leukemia. So far, Dr. June’s treatment has accomplished what nearly three years of traveling the country for various surgeries and procedures could not.

What’s next for Dr. June and his team? They hope to be able to adapt this therapy to treat other forms of cancer. Trials on patients with pancreatic cancer are scheduled to begin in the summer of 2015.

Progress continues to be made in the fight against cancer nearly every day. Subscribe to our e-newsletter to get the latest information, including health and nutrition tips, delivered right to your inbox.   

 

Joan Luden Poses Bald to Promote Breast Cancer Awareness

The Pink Breast Cancer Awareness Ribbon
The Pink Breast Cancer Awareness Ribbon

Former Good Morning America co-host Joan Luden shocked many fans when she recently posed bald on the cover of People magazine to promote cancer awareness. In an interview on Today, Joan, who lost her hair while undergoing chemotherapy for breast cancer, told fans, “We’re losing our hair in order to live and survive.”

Not an Easy Decision

While talking about her cancer journey and decision to bare her bald head in public, Joan admitted to Hoda Kotb that she was initially reluctant to pose for the magazine. “You just are never prepared for it,” she said about losing her hair during chemo. “You feel less like a woman. You feel less feminine. You feel less beautiful. You feel kind of embarrassed. You feel kind of like the ugly duckling. You lose a part of your sense of yourself.”

One More Loss

In the grand scale of things, you would think hair loss would be a small matter for cancer patients undergoing chemotherapy. But you have only to think how it feels to find a few gray hairs or notice a little thinning on top to realize how important our hair is to our appearance and sense of self. Its sudden loss during cancer treatment can be devastating to someone already struggling with the fear and loss that accompany cancer diagnosis.

A Better Solution

Non-toxic alternative cancer treatment offers a kinder, gentler way to combat cancer. Issels integrative immunotherapy works with your body to fight cancer. Our alternative cancer treatment battles cancer without the horrendous side effects, pain and embarrassing hair loss typical of chemotherapy. Find out more about the benefits of integrative immunotherapy at Issels.com.

Can Your Body Be Trained to Cure Its Own Cancer?

Can You Train To Fight Cancer?
Can You Train To Fight Cancer?

For decades, cancer patients have been limited to a trio of treatment options. While surgery, chemotherapy and radiation have their effectiveness, they also have serious drawbacks that can compromise quality of life. Continued research in the area of immunotherapy is uncovering its power to fight cancer naturally while preserving the body’s healthy cells.

The exciting concept behind immunotherapy is that uses the power of the body’s own immune system to essentially treat itself. Unlike chemotherapy, the immune system is more adaptive and able to distinguish between healthy tissue and invaders such as cancer cells. Consider the example of childhood vaccines, which remain effective over time thanks to the immune system’s memory.

One of the biggest breakthroughs came in a 2013 study conducted by Bristol-Myers Squibb. A group of 52 melanoma patients was treated with one approved and one experimental drug. Nearly one-third experienced rapid and deep tumor regression. As study leader Dr. Jedd Wolchok observed, “We have spent several decades in cancer research learning better ways to treat the tumor. Now we are learning how to treat the patient.”

Dr. David Maloney has been working on targeted cancer therapies since he was a student at Stanford in the early 1980s. He’s currently focused on a procedure wherein a patient is infused with his own T-cells that have been harvested and genetically re-engineered to become better cancer “drones”. He cites the benefit of immunotherapy as a move away from a “one-size-fits-all” approach to customized treatments.

For more than 60 years, Issels has been on the forefront of integrative immuno-oncology treatments. Visit our website to read and hear first-hand testimonials from our patients.

Diagnostic Blood Test Could Speed Cancer Treatment

Cancer Research
Cancer Research

“Promising” is the word British scientists are using to describe early results of a simple blood test that could revolutionize cancer diagnosis and speed cancer treatment. Developed by researchers at the University of Bradford in the United Kingdom, the Lymphocyte Genome Sensitivity (LGS) test may turn out to be the easy to administer, inexpensive and accurate diagnostic tool the cancer treatment community has been searching for.

How It Works

Named for the type of white blood cell it examines, the Lymphocyte Genome Sensitivity test searches for cancer-related DNA damage in cells that have been bombarded with varying degrees of ultraviolet light.

“White blood cells are part of the body’s natural defense system,” study leader Professor Diana Anderson explains on the University’s website. “We know that they are under stress when they are fighting cancer or other diseases, so I wondered whether anything measurable could be seen if we put them under further stress with UVA light. We found that people with cancer have DNA which is more easily damaged by ultraviolet light than other people.”

What It Means

The ability to diagnose cancer with a blood test that measures immune system response would decrease the need for more costly and invasive tests and biopsies. In early testing, UV damage to white blood cell DNA was able to accurately differentiate between healthy, pre-cancerous and cancerous cells. DNA damage to white blood cells became measurably more pronounced as cancer developed and advanced.

The test underscores the connection between the immune system and cancer development. By strengthening the body’s immune system, Issels integrative immunotherapy has helped many of our patients achieve complete long-term remission of advanced and therapy-resistant cancers.

Vitamin D and the Cancer Connection

Vitamin D To Reduce Risks of Cancer
Vitamin D To Reduce Risks of Cancer

Does Vitamin D offer hope for alternative cancer therapy? A new study in the journal Clinical Cancer Research suggests low blood levels of this vitamin may be linked to more aggressive, advanced cases of prostate cancer in men.

What we do know…
Vitamin D effects how cells develop and grow, regulating the differentiation of cells as they change from stem to adult cells, and regulating the growth rate of normal and cancer cells. The skin makes it when exposed to sunlight, however Vitamin D levels are known to decline with age, in certain seasons and climates, and in individuals with darker skin, which naturally blocks sunlight.

What we don’t know…
Researches haven’t yet proved a cause-and-effect relationship, and don’t yet understand how Vitamin D comes into play. They are also unsure if taking extra might reduce prostate cancer risks and offer natural cancer treatment and prevention.

What the study shows:
Among the 667 Chicago men ages 40-79 studied with abnormal prostate screenings, the majority were found to be Vitamin D deficient. In addition, among those testing positive for cancer, those with very low levels were at greater risk of advanced, aggressive varieties. In addition, black men were more likely to be diagnosed.

What about Vitamin D’s relationship to cancer?
At this point, scientists only know that the rate of prostate cell growth (in a petri dish) slows when Vitamin D is added to the mix. They are now theorizing that too little of this vitamin may cause cell growth to go awry, leading to cancer.

Researchers admit larger, more extensive studies are necessary to examine the possible connection and address the many unanswered questions prompted by the research.